NEA Management Company’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.2M | Hold |
|
|||||
|
2025
Q1 | $54M | Hold |
|
|||||
|
2024
Q4 | $62.5M | Hold |
|
|||||
|
2024
Q3 | $74.6M | Hold |
|
|||||
|
2024
Q2 | $85.8M | Hold |
|
|||||
|
2024
Q1 | $180M | Hold |
|
|||||
|
2023
Q4 | $99.4M | Hold |
|
|||||
|
2023
Q3 | $72.1M | Hold |
|
|||||
|
2023
Q2 | $89.1M | Hold |
|
|||||
|
2023
Q1 | $71.8M | Hold |
|
|||||
|
2022
Q4 | $64.5M | Sell |
|
|||||
|
2022
Q3 | $104M | Hold |
|
|||||
|
2022
Q2 | $96.6M | Hold |
|
|||||
|
2022
Q1 | $366M | Hold |
|
|||||
|
2021
Q4 | $120M | Hold |
|
|||||
|
2021
Q3 | $178M | Hold |
|
|||||
|
2021
Q2 | $257M | Hold |
|
|||||
|
2021
Q1 | $194M | Hold |
|
|||||
|
2020
Q4 | $243M | Hold |
|
|||||
|
2020
Q3 | $133M | Sell |
|
|||||
|
2020
Q2 | $154M | Hold |
|
|||||
|
2020
Q1 | $88.7M | Hold |
|
|||||
|
2019
Q4 | $127M | Hold |
|
|||||
|
2019
Q3 | $85.7M | Hold |
|
|||||
|
2019
Q2 | $98.5M | Hold |
|
|||||
|
2019
Q1 | $74.7M | Hold |
|
|||||
|
2018
Q4 | $59.7M | Hold |
|
|||||
|
2018
Q3 | $92.7M | Hold |
|
|||||
|
2018
Q2 | $123M | Sell |
|
|||||
|
2018
Q1 | $159M | Buy |
|
|||||
|
2017
Q4 | $75.6M | Hold |
|
|||||
|
2017
Q3 | $57.6M | Hold |
|
|||||
|
2017
Q2 | $51.6M | Hold |
|
|||||
|
2017
Q1 | $70.1M | Hold |
|
|||||
|
2016
Q4 | $65.3M | Buy |
|